Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Stanford University
- Study ID
- NCT07044505
- Status
- Recruiting
Conditions
- Gynecologic Cancer
- Gynecologic Disease
- Gynecological Surgery
- Uterine Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Uterine Lavage — PROCEDURESaline is introduced into the uterine cavity and retrieved during surgery to collect cells and fluid for downstream molecular and cellular analyses.
Study Details
This study is a designed as a to test the clinical and technical feasibility of using this novel uterine lavage collection catheter to collected UL samples from up to 50 individuals undergoing gynecologic surgery and to describe the cellular composition of these samples. In order to do this, it is a prospective consecutively-enrolled cohort of 50 participants, all of who will receive the intervention of uterine lavage collection.
Key Dates
- Start date
- Sep 19, 2025
- Status verified
- Nov 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Single GroupParticipants undergoing gynecologic surgery who agree to uterine lavage collection intraoperatively for molecular and cellular analysis.
Primary Outcome Measure
Characterization of cellular composition in uterine lavage fluid [ Time Frame: At time of gynecologic surgery ]
Central Contacts
- Rozelle Laquindanum(650) 724-9948
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University | Palo Alto | California | 94304 | James Ford, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Palo Alto, CA
By condition
By specialty
By research site
Related Studies
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)PHASE1/PHASE2 · Recruiting · Genmab · Phoenix, Arizona
- Insights Into Participating in Studies for Uterine CancerNot Yet Recruiting · Power Life Sciences Inc. · San Francisco, California
- PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional RecoveryRecruiting · University of California, San Francisco · San Francisco, California
- Investigations of Reproductive Cancers in WomenRecruiting · PinkDx, Inc. · Birmingham, Alabama